St. Jude Medical (STJ)

Slide schematic 16/16

list 15/15 title 1/1

Components 16

bullet bullet bullet bullet bullet bullet bullet bullet bullet bullet bullet bullet bullet bullet bullet headline

Tools 1

R&D: R&D is expected to remain in the 12.5% to 13% of sales range in our model and where management has been guiding for 2016.,Cardiovascular Segment Growth: According to management, the Cardiovascular segment is expected to grow 1% to 3% for 2016.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

The slide outlines specific adjustments to management guidance for various segments (CRM, Heart Failure, AF, Cardiovascular, Neuromodulation) and financial metrics (Margins, SG&A, R&D, Capex) to reflect a stress-test scenario.